Pharmacology antiandrogens value androgen suppression antiandrogen therapy Antiandrogens able effect androgens target cells binding androgen receptor AR chemical classes antiandrogens market clinical trials steroids cyproterone acetates nonsteroids flutamide Steroid antiandrogens interact AR progestin glucocorticoid receptors rise glucocorticoid effects contrast nonsteroid antiandrogens AR devoid hormonal antihormonal activities Nilutamide active metabolite flutamide interacts dog rat human prostate AR vitro kinetics prolonged interaction AR vivo administration prostate cancer treatment necessary antiandrogen surgical chemical LH-RH agonists castration complete suppression androgens antiandrogen target site trophic effect adrenal androgens intact castration secretion treatments adrenalectomy ketoconazole corticoid synthesis nilutamide trophic effect prostate castrated rats adrenal androgens minipumps levels similar castrated men Nilutamide flare-up effect testosterone increase LH-RH agonists beginning treatment rat buserelin increase prostate weight initial days treatment LH-RH agonist combined treatment nilutamide combined treatment nilutamide castration experimental androgen-dependent cancer model Shionogi tumor administration nilutamide twenty-four hours inoculation tumor cells appearance tumors number absence androgen effect antiandrogen activity product human tumor cells culture cells MMTV androgen-dependent promoter CAT reporter gene 